Your browser doesn't support javascript.
loading
MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Alspach, Elise; Lussier, Danielle M; Miceli, Alexander P; Kizhvatov, Ilya; DuPage, Michel; Luoma, Adrienne M; Meng, Wei; Lichti, Cheryl F; Esaulova, Ekaterina; Vomund, Anthony N; Runci, Daniele; Ward, Jeffrey P; Gubin, Matthew M; Medrano, Ruan F V; Arthur, Cora D; White, J Michael; Sheehan, Kathleen C F; Chen, Alex; Wucherpfennig, Kai W; Jacks, Tyler; Unanue, Emil R; Artyomov, Maxim N; Schreiber, Robert D.
Afiliação
  • Alspach E; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Lussier DM; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
  • Miceli AP; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Kizhvatov I; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
  • DuPage M; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Luoma AM; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
  • Meng W; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Lichti CF; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Esaulova E; Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.
  • Vomund AN; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Runci D; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Ward JP; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
  • Gubin MM; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Medrano RFV; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
  • Arthur CD; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • White JM; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Sheehan KCF; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Chen A; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
  • Wucherpfennig KW; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Jacks T; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
  • Unanue ER; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Artyomov MN; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
  • Schreiber RD; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.
Nature ; 574(7780): 696-701, 2019 10.
Article em En | MEDLINE | ID: mdl-31645760

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe II / Antígenos de Neoplasias / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe II / Antígenos de Neoplasias / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article